Siemens Medical Solutions received FDA 510(k) clearance for a 1.5 Tesla (T) magnetic resonance imaging (MRI) system that is reportedly more affordable, allowing providers to upgrade from low-field MRI systems or to add an MRI system for the first time.
October 17, 2007 — Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers.
The Philips Step and Shoot Cardiac solution has reportedly been shown to save up to 80 percent of the dose in a cardiac exam. As the newest cardiac imaging innovation for the Philips Brilliance CT 64-channel scanner, it provides high quality CT images at low radiation dose. An axial prospective ECG-gated acquisition technique reportedly achieves full heart coverage within a short breath-hold.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 17, 2007 - Positron Corp. introduced its new dedicated-Cardiac PET system, Attrius, at the annual meeting of the ...
The FLAIR Endovascular Stent Graft treats stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) grafts in hemodialysis patients to increase blood flow.
October 17, 2007 - Boston Scientific Corp. will be presenting safety and efficacy data on its TAXUS Express2 and TAXUS ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Toshiba Aquilion CT line’s product platform design reportedly allows for all customers to benefit from Toshiba’s ...
October 17, 2007 - CryoCor, Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that CryoCath Technologies Inc. has filed a lawsuit against CryoCor in the United States District Court for the District of Delaware alleging that CryoCor infringes several of CryoCath’s U.S. patents.
Agfa HealthCare’s DX-S reportedly fills the gap in the current range of Digital Radiography Solutions by providing a ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 16, 2007 – Celera developed a five-gene genetic risk score based on five variant genes that predict risk for coronary heart disease (CHD), according to a study published in the October 2007 edition of Genetics in Medicine, marking the potential development of personalized disease management in the cardiovascular arena.
Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.
October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for lead fractures, and the company recommends that physicians do no perform new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device ...
The clinical definition of intraoperative awareness — consciousness during general anesthesia — is a seemingly simple explanation for a complex, and controversial, phenomenon. Opinions surrounding how often intraoperative awareness, also described as anesthesia awareness, occurs, its implications for victims, as well as the best methods for prevention are varied.
October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).